Third Harmonic Bio Inc. Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
2020
-20M
-31M
0M
10M
0M
0M
0M
0M
1M
0M
-0 %
0M
0M
0M
269M
-20M
289M
-21M
-35M
-35M
0M
5M
0M
-5M
0M
0M
196M
0M
-0 %
0M
0M
-2M
289M
161M
128M
-35M
-16M
-30M
0M
1M
11M
3M
0M
0M
136M
0M
-0 %
0M
0M
136M
128M
120M
8M
-16M
-9M
-13M
0M
0M
2M
2M
0M
0M
11M
0M
-0 %
0M
0M
11M
8M
2M
7M
-9M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
4Q2021
3Q2021
2Q2021
1Q2021
-6M
-7M
0M
2M
2M
-1M
0M
0M
1M
0M
-0 %
0M
0M
0M
269M
-5M
274M
-6M
-4M
-7M
0M
2M
0M
1M
0M
0M
0M
0M
-0 %
0M
0M
0M
274M
-4M
279M
-4M
-4M
-8M
0M
3M
0M
1M
0M
0M
0M
0M
-0 %
0M
0M
0M
279M
-4M
283M
-4M
-7M
-9M
0M
3M
0M
0M
0M
0M
0M
0M
-0 %
0M
0M
0M
283M
-7M
289M
-7M
-9M
-11M
0M
2M
0M
0M
0M
0M
-1M
0M
-0 %
0M
0M
-199M
289M
-10M
300M
-9M
-11M
-8M
0M
1M
0M
-4M
0M
0M
198M
0M
-0 %
0M
0M
198M
300M
187M
113M
-11M
-7M
-8M
0M
1M
0M
0M
0M
0M
-1M
0M
-0 %
0M
0M
0M
113M
-7M
120M
-7M
-8M
-8M
0M
0M
0M
-1M
0M
0M
0M
0M
-0 %
0M
0M
0M
120M
-8M
128M
-8M
-4M
-16M
0M
0M
10M
1M
0M
0M
120M
0M
-0 %
0M
0M
0M
128M
115M
13M
-4M
-4M
-7M
0M
0M
2M
1M
0M
0M
0M
0M
-0 %
0M
0M
0M
13M
-4M
17M
-4M
-4M
-3M
0M
0M
0M
0M
0M
0M
8M
0M
0 %
0M
0M
0M
17M
4M
0M
0M
-4M
-3M
0M
0M
0M
0M
0M
0M
8M
0M
0 %
0M
0M
0M
0M
4M
0M
0M